RETA

Reata Pharmaceuticals, Inc. Class A Common Stock

Delisted

RETA was delisted on the 25th of September, 2023.

181 hedge funds and large institutions have $2.69B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 71 increasing their positions, 55 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
181
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$39.3M
Puts
$94.7M
Net Calls
Net Calls Change

Top Buyers

1 +$63.3M
2 +$22.1M
3 +$11.6M
4
Morgan Stanley
Morgan Stanley
New York
+$9.65M
5
SI
Sofinnova Investments
California
+$7.84M

Top Sellers

1 -$42.5M
2 -$36.6M
3 -$11.1M
4
Ameriprise
Ameriprise
Minnesota
-$10.1M
5
CA
Corriente Advisors
Texas
-$10.1M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$3.44M
52
$3.33M
53
$3.19M
54
$3.13M
55
$3.06M
56
$3.05M
57
$3.03M
58
$2.96M
59
$2.79M
60
$2.73M
61
$2.72M
62
$2.71M
63
$2.67M
64
$2.62M
65
$2.59M
66
$2.58M
67
$2.26M
68
$2.24M
69
$2.21M
70
$2.11M
71
$2.01M
72
$2.01M
73
$2M
74
$1.91M
75
$1.86M